aTyr Pharma Inc (LIFE)
1.625
+0.04
(+2.20%)
USD |
NASDAQ |
Apr 18, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Cash from Operations (TTM): -33.22M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -33.22M |
September 30, 2023 | -32.53M |
June 30, 2023 | -35.25M |
March 31, 2023 | -32.36M |
December 31, 2022 | -41.89M |
September 30, 2022 | -39.60M |
June 30, 2022 | -38.79M |
March 31, 2022 | -37.37M |
December 31, 2021 | -33.08M |
September 30, 2021 | -30.39M |
June 30, 2021 | -24.48M |
March 31, 2021 | -23.19M |
December 31, 2020 | -15.30M |
September 30, 2020 | -14.82M |
June 30, 2020 | -13.51M |
March 31, 2020 | -11.93M |
December 31, 2019 | -20.01M |
September 30, 2019 | -19.94M |
June 30, 2019 | -22.14M |
Date | Value |
---|---|
March 31, 2019 | -26.51M |
December 31, 2018 | -31.06M |
September 30, 2018 | -36.53M |
June 30, 2018 | -38.96M |
March 31, 2018 | -39.05M |
December 31, 2017 | -42.36M |
September 30, 2017 | -43.75M |
June 30, 2017 | -49.55M |
March 31, 2017 | -54.26M |
December 31, 2016 | -52.86M |
September 30, 2016 | -51.00M |
June 30, 2016 | -45.78M |
March 31, 2016 | -43.00M |
December 31, 2015 | -36.80M |
September 30, 2015 | -32.76M |
June 30, 2015 | -29.07M |
March 31, 2015 | -22.76M |
December 31, 2014 | -22.82M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-41.89M
Minimum
Dec 2022
-11.93M
Maximum
Mar 2020
-27.36M
Average
-30.39M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Vaxart Inc | -70.45M |
Allogene Therapeutics Inc | -237.73M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |